Nearly 1,000 people attend Ovarian Cancer Research Alliance Rivkin Family SummeRun

Published 3:30 pm Thursday, July 16, 2026

People turned out in droves for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun on the morning of July 12 at Seward Park in Seattle.

The event was focused on raising critical funds for ovarian cancer research and featured a Sprinters Kids Fun Run with 40 participants ages 2-9 and a 5K Run/Walk. The event raised close to $250,000.

Mercer Island’s Dr. Saul E. Rivkin founded the Rivkin Center for Ovarian Cancer Research after his wife Marsha died of ovarian cancer at age 49 after a four-year battle in 1993. At the finish line, Rivkin personally greeted participants as they completed the course, which is “a cherished tradition that continues to make SummeRun so meaningful for so many families,” reads a press release.

This year, nearly 1,000 runners, walkers, survivors, families, friends and supporters participated in the event, one of the nation’s longest-running events dedicated to funding ovarian cancer research. The event included 50 ovarian and gynecologic cancer survivors.

Participants of all ages and abilities transformed the park into a sea of teal and purple, with ovarian cancer survivors wearing teal event shirts and all other participants wearing purple in a moving show of solidarity, remembrance, and hope, added a press release.

Special guest Mortimer “Mariner” Moose, the Seattle Mariners’ mascot, led the Fun Run and each child received a commemorative finisher medal.

“SummeRun 2026 was a tremendous success,” said Audra Moran, president and CEO of OCRA, which runs the event. “This event was founded by Dr. Saul Rivkin and his five daughters in memory of his late wife, Marsha Rivkin, more than three decades ago, and has since raised more than $10 million to advance critical ovarian cancer research. Since the Rivkin Center joined OCRA in 2025, OCRA has proudly continued the tradition while carrying forward the Rivkin family’s extraordinary commitment to scientific discovery and better outcomes for patients everywhere.”

For more information, visit: https://summerun.ocrahope.org/.